Targeting IFN- To B Cell Lymphoma by a Tumor-Specific Antibody Elicits Potent Antitumor Activities

Journal of Immunology - United States
doi 10.4049/jimmunol.179.10.6881
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Correction To: Adenovirus-Mediated LIGHT Gene Modification in Murine B-Cell Lymphoma Elicits a Potent Antitumor Effect

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2020English

Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Dendritic Cells Combined With Tumor Cells and Α-Galactosylceramide Induce a Potent, Therapeutic and NK-cell Dependent Antitumor Immunity in B Cell Lymphoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Tumor-Targeting NIRF NanoGUMBOS With Cyclodextrin-Enhanced Chemo/Photothermal Antitumor Activities

English

Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3

Frontiers in Pharmacology
Pharmacology
2018English

IFN-β Is a Highly Potent Inhibitor of Gastroenteropancreatic Neuroendocrine Tumor Cell GrowthIn Vitro

Cancer Research
Cancer ResearchOncology
2006English

DNA VACCINATION OF BISON TO BRUCELLAR ANTIGENS ELICITS ELEVATED ANTIBODY AND IFN-γ RESPONSES

Journal of Wildlife Diseases
EvolutionEcologySystematicsBehavior
2011English

B Cell Activation in Specific Polysaccharide Antibody Deficiency

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy